JavaScript is unavailable or disabled; so you are probably going to miss out on a few things. Everything should still work, but with a little less pzazz! Skip to main content
The William Harvey Research Institute - Barts and The London

Collaborate with us

What type of studies do we support?

The CVCTU supports Clinical Trials of Investigational Medicinal Products (CTIMPs), non-CTIMPs (which include trials of complex interventions) and device studies, whether these are single-centre, multi-centre, national or international studies. The aim is to support local investigators to deliver high-quality trials by providing oversight of the main trial activities. The CVCTU is a core resource providing infrastructure support for clinical cardiovascular research.

What services will the Barts CTU provide?

If you wish to have the Barts CVCTU as your official trials unit for a study, it will provide oversight of the main trial activities, and also provide specific resource services as requested, which may include:

Trial design, risk assessment,  protocol development, obtaining approvals (MHRA, NRES, NHS), regulatory and ethics submissions, statistical design and analysis, study oversight, data management, database development and CRF design, randomisation and emergency un-blinding,  and IMP management.

What is the process for Barts CVCTU portfolio adoption?

If you are interested in seeking our advice or collaborating with us on a study, please get in touch by email. We recommend making contact at an early stage and preferably at the point of grant application development. By contacting us early this will enable you to take full advantage of our experience and expertise. Our CVCTU Flowchart [PDF 41KB] explains the current procedure if you would like our clinical Trials Unit support for your study.

What should I do if I would like support from the Barts CVCTU?

To gain adoption onto the CVCTU portfolio, you need to submit the CVCTU Enquiry form [DOC 277KB] confirming full or outline submission to the CVCTU team - Email: CVCTU@qmul.ac.uk

A member of the team will then be in touch to discuss your proposals and assist in the submission process. The Study will then be reviewed by the CVCTU Scientific & Resource Committees.

Please aim to submit your enquiry form to us 8 weeks prior to the funding deadline for a full submission, and at least 4 weeks prior for an outline funding submission, otherwise we cannot guarantee to provide a complete review and response by your application deadline. 

CVCTU Review and Adoption

If this study is funded, we will levy a fee for the time spent on adoption process whether CVCTU services are used or not.

The fee is:

Commercially funded study, investigator led (with an internal PI)   2.5% of the total value of the grant awarded up to a value of <400,000, with a minimum of £2.5 K, and a flat fee of £10 K for any with total grant of > 400 K.
Commercially funded study (external PI/organisation) £10,000
Non-commercial studies with a  recruitment target of <20 patients with short study duration of 1 year irrespective of follow-up £1,500
Non-commercial studies with a recruitment target of >20 patients  1% of the total value of the grant awarded up to a maximum of £7.5k and with absolute minimum of £2.0K

 

Contact

Barts CVCTU Cardiovascular Clinical Trials Unit (CVCTU)
William Harvey Research Centre
Barts and the London School of Medicine and Dentistry
Queen Mary University of London
Charterhouse Square
London, EC1M 6BQ

Phone: +44(0) 20 7882 5673 (Anna Bellin)
Email: CVCTU@qmul.ac.uk